Sunday 18 October 2026 Export VNDA’s income statement to Excel — free account

Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $216.1 million, up 8.72% from fiscal 2024. In the quarter to June 2026, revenue fell 3.92%, EPS fell 126.1%, free cash flow fell 101.0% and total debt rose 2.98%, each against the same quarter a year earlier.

4.03 0.21 −4.95%

Follow VNDA

Alert me

Market cap: $256.4M
P/E: 0.0×
Fwd P/E: −2.6×
Dividend yield: —
F-score: 2/9
Altman Z: 0.72
Beneish M: −3.88
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	2	2	2	3	+8 more TTM periods Free account
ROE Full definition →	(77.81%)	(60.48%)	(50.93%)	(16.72%)
ROA Full definition →	(53.00%)	(44.97%)	(38.51%)	(13.51%)
ROIC Full definition →	(217.59%)	(121.87%)	(140.15%)	(43.23%)
Return on Tangible Assets Full definition →	(266.75%)	(149.87%)	(107.89%)	(33.40%)
Average Days of Receivables Full definition →	101.00	95.33	92.18	86.99
Free Cash Flow per Share Full definition →	(2.54)	(2.31)	(1.87)	(1.40)
Free Cash Flow Full definition →	(153.00)	(137.30)	(110.44)	(82.95)
Capital Expenditures Full definition →	(10.67)	(10.78)	(1.00)	(1.11)
Other line items
Cash ROIC Full definition →	(38.89%)	(28.20%)	(18.56%)	(10.88%)
Accounts Receivable Turnover Full definition →	4.12	4.29	4.25	4.55
Accounts Payable Turnover Full definition →	0.21	0.24	0.24	0.27
Inventory Turnover Full definition →	7.02	7.00	7.29	6.46
Average Days of Payables Full definition →	1,891.59	1,744.70	1,911.10	1,472.84
Days of Inventory on Hand Full definition →	45.35	48.90	51.82	63.16
Tax Rate Full definition →	0.55	0.60	0.59	(0.21)
Research and Development Expense of Revenue Full definition →	54.22%	46.83%	50.56%	47.20%
Selling, General and Administrative Expense of Revenue Full definition →	122.13%	117.65%	110.11%	101.03%
Share Based Compensation of Revenue Full definition →	4.20%	4.16%	4.38%	4.74%
Operating CF/Net income Full definition →	0.52	0.53	0.50	0.97
Depreciation/Fixed assets Full definition →	4.85	4.98	4.39	2.59
Capex/Depreciation Full definition →	(0.85)	(0.96)	(0.10)	(0.17)
Revenue per Share Full definition →	3.58	3.66	3.67	3.59
Operating CF per Share Full definition →	(2.36)	(2.13)	(1.86)	(1.38)
Capex per Share Full definition →	(0.18)	(0.18)	(0.02)	(0.02)
Capex to Sales Full definition →	0.05	0.05	0.00	0.01

Fold the line items

Columns are period end dates

Stockrow Weekly